Related Experiment Video

Updated: Apr 23, 2026

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
10:44

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

12.7K

Dexamethasone-Mediated Regulation of CYP3A4 and UGTs in Human Hepatoma HuH-7 Cells

Hana Yu1, Song Hee Lee1, Ji Hyeon Kim1

  • 1College of Pharmacy and Integrated Research Institute of Pharmaceutical Sciences, The Catholic University of Korea, Bucheon, South Korea.

Fundamental & Clinical Pharmacology
|April 21, 2026
PubMed
Abstract

Insights

Dexamethasone (DEX) boosts drug-metabolizing enzyme (DME) activity in HuH-7 cells via glucocorticoid receptor (GR) activation. However, these cells lack key regulatory pathways found in primary hepatocytes, limiting their use in drug discovery.

Area of Science:

  • Hepatology and Drug Metabolism
  • Pharmacology and Toxicology

Background:

  • Human hepatic cell lines have limited use in drug discovery due to low drug-metabolizing enzyme (DME) levels.
  • Primary human hepatocytes (HPHs) are the gold standard but are difficult to obtain and maintain.

Purpose of the Study:

  • To investigate the effect of dexamethasone (DEX) on DME expression and activity in HuH-7 hepatoma cells.
  • To understand the regulatory mechanisms of DMEs in this cell line.

Main Methods:

  • HuH-7 cells were treated with DEX, nuclear receptor agonists, and antagonists.
  • Drug-metabolizing enzyme (CYP and UGT) expression and activity were assessed using immunoblotting and probe substrate assays.
  • Transcriptional regulation was evaluated by examining the effects of receptor inhibitors and agonists.

Main Results:

  • DEX significantly increased the expression and activity of CYP3A4, UGT1A1, and UGT2B7 in HuH-7 cells.
  • DEX-induced CYP3A4 upregulation was mediated by glucocorticoid receptor (GR) activation, not pregnane X receptor (PXR).
  • HuH-7 cells did not exhibit transcriptional regulation of DMEs by PXR or constitutive androstane receptor (CAR) agonists, unlike HPHs.

Conclusions:

  • DEX treatment can enhance the activity of key DMEs (CYP3A4, UGT1A1, UGT2B7) in HuH-7 cells, likely through GR activation.
  • The absence of PXR and CAR-mediated transcriptional regulation in HuH-7 cells limits their utility for assessing drug-induced DME changes.
  • Further research is needed to identify suitable cell models for evaluating drug metabolism in early drug discovery.
Keywords:
HuH‐7 cellsconstitutive androstane receptor (CAR)cytochrome P450 (CYP)dexamethasone (DEX)glucocorticoid receptor (GR)pregnane X receptor (PXR)uridine 5′‐diphospho‐glucuronosyltransferase (UGT)

More Related Videos

Stabilizing Hepatocellular Phenotype Using Optimized Synthetic Surfaces08:50

Stabilizing Hepatocellular Phenotype Using Optimized Synthetic Surfaces

Published on: September 26, 2014

9.6K
An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

7.3K

Related Concept Videos

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450...
325
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
93
Phase II Reactions: Glucuronidation01:24

Phase II Reactions: Glucuronidation

Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
2.1K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
80
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
792
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.7K